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Class III PI3K regulates organismal glucose
homeostasis by providing negative feedback
on hepatic insulin signalling
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Defective hepatic insulin receptor (IR) signalling is a pathogenic manifestation of metabolic
disorders including obesity and diabetes. The endo/lysosomal trafficking system may
coordinate insulin action and nutrient homeostasis by endocytosis of IR and the autophagic
control of intracellular nutrient levels. Here we show that class III PI3K—a master regulator of
endocytosis, endosomal sorting and autophagy—provides negative feedback on hepatic
insulin signalling. The ultraviolet radiation resistance-associated gene protein (UVRAG)-
associated class III PI3K complex interacts with IR and is stimulated by insulin treatment.
Acute and chronic depletion of hepatic Vps15, the regulatory subunit of class III PI3K,
increases insulin sensitivity and Akt signalling, an effect that requires functional IR. This is
reflected by FoxO1-dependent transcriptional defects and blunted gluconeogenesis in Vps15
mutant cells. On depletion of Vps15, the metabolic syndrome in genetic and diet-induced
models of insulin resistance and diabetes is alleviated. Thus, feedback regulation of IR
trafficking and function by class III PI3K may be a therapeutic target in metabolic conditions
of insulin resistance.
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C
atabolic and anabolic processes are tightly coordinated in
response to nutrient and energy availability. The traffick-
ing of endocytic and autophagic vacuoles to the lysosomal
degradation system is a key event to satisfy the energetic needs of
the cell after food intake or during starvation. Insulin, the major
anabolic hormone in mammals, is released by pancreatic beta
cells into the bloodstream after food intake and acts in peripheral
tissues by binding transmembrane insulin receptor (IR) with
tyrosine kinase activity1. The endocytosis of IR plays an
important role in the magnitude and nature of insulin signals.
Depending on the tissues, IR can be internalized at the caveolae,
which are invaginations of the plasma membrane, or at clathrin-
coated pits2–4. The internalization of IR and sorting to the
lysosomes is a major pathway to degrade receptor and to remove
hormone from the circulation thus terminating insulin action1,5.
However, in the endosomes, IR maintains its activity and
interacts with signal transduction elements6. Insulin receptor
substrates (IRS1–4) act as signalling scaffolds at both the plasma
membrane and endosomes, where essential proteins for the
metabolic action of insulin are recruited, such as class I PI3K, IRS
and Akt kinases1,7,8. In addition to being regulated by the endo/
lysosomal system, insulin signalling tightly controls autophagy.
Autophagy is a process by which proteins and organelles are
engulfed in double-membrane autophagosomes and degraded
after fusion with lysosomes9. Insulin inhibits the autophagic
degradation of cellular components, while favouring nutrient
uptake and usage from the extracellular milieu. Consistent with a
central role in nutrient homeostasis, a growing body of evidence
indicates that defects in the endocytosis and autophagy
may contribute to metabolic syndromes10. Defects in IR
internalization have been associated with obesity and type 2
diabetes (T2D), both in humans and in animal models11,12.
Autophagy defects have a complex and controversial influence on
insulin resistance and nutrient homeostasis13–15.
Among the molecular mechanisms coordinating endocytosis
and autophagy, class III PI3K has a central evolutionarily
conserved role. Class III PI3K is present in every eukaryotic cell,
from yeast, in which it was initially discovered, to mammals16.
It is constituted by a complex of the regulatory and catalytic
subunits Vps15 and Vps34, respectively. Vps15 is a putative
serine/threonine protein kinase, which is required for Vps34
stability, activity and membrane targeting17. The lipid kinase
activity of Vps34 is a major source of phosphatidylinositol
3-phosphate (PI3P) in the cell, which functions as secondary
messenger at the intracellular membranes and docking signal for
proteins containing PI3P-binding domains, such as FYVE or PX
(ref. 18). Binding to PI3P promotes the formation of protein
scaffolds that are involved in multiple processes, including
autophagy, trafficking from the plasma membrane towards the
lysosome and endosomal sorting. Both autophagic and endocytic
trafficking require class III PI3K activity. It is now becoming clear
that class III PI3K contributes to these pleiotropic functions by
engaging in distinct protein complexes. Binding of Atg14-related
protein (ATG14) or ultraviolet radiation resistance-associated
gene protein (UVRAG) to a Vps34/Vps15/Beclin-1 complex
is mutually exclusive19,20. The ATG14-containing complex
stimulates Vps34 activity at the phagophore membranes and is
required for autophagy initiation in response to nutrient
withdrawal. The UVRAG-containing complex is implicated in
endosome and autophagosome maturation. The majority of
Vps34/Vps15 in mammalian cells is not in complex with ATG14
and UVRAG, the existence of additional complexes is likely21.
Vps34/Vps15 activity is now thought to integrate environ-
mental cues. Glucose starvation increases class III PI3K activity,
in both ATG14- and UVRAG-containing complexes, through an
AMP-activated kinase (AMPK)-dependent mechanism22. During
conditions of amino-acid starvation that promote autophagy,
class III PI3K activity in ATG14-containing complexes is
specifically stimulated, whereas the majority of Vps34
complexes are inhibited. This is due to the ability of ATG14 to
recruit the Ulk1 kinase, which is activated by amino-acid
starvation and phosphorylates Beclin-1 to promote autophagy23.
Less clear is the impact of insulin on class III PI3K activity.
Although insulin does not appear to affect total class III PI3K
activity24, the effect of insulin treatment on specific Vps34/Vps15
complexes has never been reported.
We show that UVRAG-containing class III PI3K complexes are
effectors of insulin action that associate with IR. Moreover,
perturbing class III PI3K activity has a major impact on the
kinetics of IR degradation, as well as on downstream signal
transduction. As a result, we demonstrate that targeting Vps15
has a beneficial metabolic effect in mouse models of obesity and
T2D. These data define class III PI3K as a crucial element in the
response to insulin and nutrients (glucose and amino acids) at the
crossroad of autophagy and IR trafficking.
Results
Loss of Vps15 delays IR degradation and promotes signalling.
To analyse the role of class III PI3K in IR responses and meta-
bolic homeostasis, we first depleted Vps15 using a specific shRNA
in mouse hepatocellular carcinoma Hepa1.6 cells. In line with its
requirement for the class III PI3K complex stability25, the
downregulation of Vps15 was paralleled by decreased levels of
other core components of the complex—Vps34 and Beclin-1
(Fig. 1a). We revealed that Akt signalling, a major downstream
effector of activated IR8, was upregulated in Vps15-depleted cells
(Fig. 1a and Supplementary Fig. 1a), as indicated by increased
phosphorylation of Akt and its substrate proline-rich Akt
substrate of 40 kDa (Pras40) protein. These observations
prompted us to hypothesize that IR turnover could be affected
in Vps15-depleted cells. To test this possibility, we followed IR
levels on insulin stimulation. In control scrambled hairpin
(shSCR)-treated cells, 50% of the catalytic subunit of IR, IRb,
was degraded 3 h after insulin stimulation (Fig. 1b and
Supplementary Fig. 1a), suggesting receptor internalization and
degradation in the lysosomes on exposure to the agonist.
Interestingly, depletion of Vps15 impaired IRb degradation,
concomitant with increased insulin signalling, as measured by
Akt phosphorylation (Fig. 1b and Supplementary Fig. 1a).
Importantly, the effects of Vps15 depletion on IR levels and
downstream Akt activation could be rescued by overexpression of
recombinant hVps15 protein resistant to shRNA (Fig. 1c).
In addition, the improved insulin signalling in Vps15-depleted
cells was evidenced by increased complexes between IR and
its downstream effectors (Supplementary Fig. 1b,c). Next, we
analysed primary hepatocytes from Vps15f/f mice transduced
with Cre recombinase-expressing adenoviral vector. As previously
observed26, CRE-mediated recombination of exon 2 in Vps15
gene led to the expression of non-functional truncated Vps15
protein due to the usage of alternative start codon in the
exon 4 (Supplementary Fig. 2a). As expected, depletion of Vps15
in hepatocytes resulted in loss of class III PI3K complex
expression (Supplementary Fig. 2a). Importantly, IR levels
decreased in control hepatocytes on insulin stimulation, while
they remained constant in mutant cells (Supplementary Fig. 2b,c).
Importantly, the insulin-stimulated IR degradation to large
extend could be rescued by inhibition of lysosomal activity
confirming that the lysosomal pathway is a major route of
receptor degradation (Supplementary Fig. 2b). The lower basal
levels of IRb in primary cultures of Vps15-depleted hepatocytes
likely reflected compensatory mechanisms due to persistent
pathway activation. Consistent with the results in Hepa1.6 cells,
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insulin-stimulated Akt phosphorylation was also upregulated in
Vps15-depleted hepatocytes (Supplementary Fig. 2c). In sum,
both in hepatocellular carcinoma cells and in primary hepatocytes
Vps15 depletion interferes with IR degradation and results in
improved Akt signalling.
Vps15 inactivation results in accumulation of the endosomes.
Class III PI3K-dependent production of PI3P on endosomes is
required for the recruitment of PI3P-binding domain-containing
proteins that regulate different steps of endocytosis. In agreement,
Vps15 depletion impaired the recruitment of the PI3P probe
2xFYVE to the endosomal compartment, providing additional
evidence for the loss of class III PI3K activity in Vps15-depleted
cells (Fig. 1d). Perturbed endosomal plasticity on Vps15 loss
in primary hepatocytes was further evidenced by striking
vacuolization and expansion of the Lamp1-positive compartment
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Figure 1 | IR signalling is induced in Vps15-depleted cells. (a) Hepa1.6 cells were transduced with adenoviral vectors expressing shRNAVps15 or shRNA
SCR as a negative control. The 48-h post-transduction expression of components of class III PI3K and status of Akt-signalling pathway was revealed by
immunoblot analysis. Immunoblot with anti-GAPDH antibodies was used as a loading control. Densitometric analyses of phosphorylated proteins
normalized to total protein levels are presented on Supplementary Fig. 1a. (b) Hepa1.6 cells were transduced with shRNAVps15- or shRNA SCR-expressing
adenoviruses. The 24-h postinfection cells were serum starved for 24 h followed by stimulation with 1 mM insulin (Ins). IR levels and status of the pathway
activation was determined by immunoblot analysis. Densitometric analyses of phosphorylated Akt normalized to total Akt level and actin-normalized IRb
levels are presented on Supplementary Fig. 1a. (c) Hepa1.6 cells were transduced with GFP, shRNA Vps15 or shRNA Vps15 in combination with hVps15
cDNA-expressing adenoviruses. The 24-h postinfection cells were serum starved for 24 h followed by stimulation with 1 mM insulin for 1 h. IR levels
and status of Akt-signalling pathway activation was determined by immunoblot analysis. (d) Vps15f/f primary hepatocytes were transduced with
Adeno-b-Gal- or Adeno-CRE-expressing vectors. To detect endogenous PI3P, 48-h postinfection hepatocytes were transfected with the reporter plasmid
expressing 2xFYVE-GFP fusion protein. Cells were kept in the nutrient-rich media supplemented with 10% FBS and insulin, 24-h post-transfection cells
were PFA fixed and PI3P-positive compartments (endosomes) were visualized by confocal microscopy. Scale bar, 10mm. (e) Vps15f/f primary hepatocytes
were transduced with Adeno-GFP or Adeno-CRE vectors. Cells were kept in the nutrient-rich media supplemented with 10% FBS and insulin. The 72-h
post-transduction cells were collected and endosomal fraction prepared from the equal mass of cells. Equal volumes of endosomal fraction were loaded for
Adeno-GFP or Adeno-CRE samples. Total protein extracts were prepared from the fraction of pelleted cells. The protein concentration in the extracts was
measured by Bradford and the equal amount of proteins (10 mg) was loaded for each sample. Proteins present in endosomal fraction and in total extracts
were revealed by immunoblot analysis. Immunoblot with anti-VDAC, anti-GAPDH and anti-Tubulin antibodies served as a control of purity of endosomal
fraction for mitochondria proteins, cytoplasmic proteins and cytoskeletal proteins, respectively.
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(Supplementary Fig. 2d). Similarly, the immunofluorescent
studies of Hepa1.6 cells revealed profound perturbations of
endolysosomal compartment on short-term Vps15 down-
regulation (Supplementary Fig. 1d). In addition, endosome
purification by differential centrifugation in sucrose gradient
revealed increased levels of endosomal markers in Vps15 mutant
hepatocytes, as assessed by the immunoblot analysis of the early
and late endosomal proteins Rab5 and Lamp1, respectively
(Fig. 1e). Of note, in Vps15-depleted cells compared with green
fluorescent protein (GFP)-transduced cells, IRb levels were
enriched in the endosomal fraction unlike in total cell extracts.
Slow kinetics of IR trafficking in Vps15-depleted cells. To study
the dynamics of IR trafficking we transiently overexpressed
red fluorescent protein (RFP)-tagged human IRb. RFP-IRb was
detected at the plasma membrane and in small endosomes in
control and Vps15-depleted Hepa1.6 cells (Fig. 2a). RFP-IRb was
also present on enlarged vacuolar endosomes uniquely in Vps15-
depleted cells, suggesting strong endocytic trafficking defects of
the receptor (Fig. 2a). We performed live cell imaging of these
cells to track RFP-IRb-labelled endosomes and quantified their
movement parameters (Supplementary Movie). The tracking of
RFP-IRb-positive small endosomes revealed that Vps15
inactivation resulted in a global reduction of the velocity of this
population (Fig. 2b). This was further reflected by a 50% decrease
in the average velocity of RFP-IRb-positive endosomes (Fig. 2c).
Together, these data reveal the accumulation of IR on enlarged
and static endosomes on Vps15 depletion. These observations also
suggest that defective IR degradation observed in Vps15-inacti-
vated cells is a direct consequence of trafficking defect that delays
receptor delivery into lysosomes.
Block of endocytosis improves IR signalling. To confirm that
defects in receptor degradation lead to improved IR signalling in
Vps15-depleted cells, IR internalization and trafficking was
blocked using the selective inhibitor of clathrin function, PitStop2
(ref. 27). As expected, endocytosis inhibition in control cells
largely prevented IRb degradation resulting in increased IRb
tyrosine phosphorylation (Fig. 2d). On the contrary, clathrin
inhibition had no effect on IRb stability and phosphorylation in
Vps15-depleted cells. Importantly, the interference with IRb
endocytic trafficking and degradation in control cells mimicked
the effect of Vps15 depletion on insulin signalling as evidenced
by increased Akt phosphorylation and phosphorylation of its
downstream target Pras40 (Fig. 2d and Supplementary Fig. 1e).
Altogether, these results demonstrate that IR signalling is
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Figure 2 | IR trafficking is impaired on class III PI3K inactivation. (a) Hepa1.6 cells were transduced with shRNA Vps15- or shRNA SCR-expressing
adenoviruses. IRb-RFP was overexpressed 24 h postinfection and cells were imaged 24h post-transfection. Representative spinning disc confocal snap shot
image of the live cell used for endosome tracking is presented (the corresponding movie is available as a Supplementary Information File). Endosomes were
manually tracked using MetaMorph software. Cumulative endosome velocity (b) and average endosome velocity (c) were calculated for each endosome.
Data are means±s.d. (n¼ 95–125 endosomes, *Po0.001 versus Adeno-shRNA SCR, Mann–Whitney Rank-sum test). (d) Hepa1.6 cells were transduced
with shRNAVps15- or GFP-expressing adenoviruses. The 24-h postinfection cells were serum starved for 24 h followed by stimulation with 1 mM insulin for
2 h. Before stimulation with insulin, cells were pretreated with 3 mM of PitStop2 inhibitor for 15min. IRb levels and status of the pathway activation was
determined by immunoblot analysis. Densitometric analyses of phosphorylated Akt and Pras40 normalized to levels of total proteins are presented on
Supplementary Fig. 1e.
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potentiated on class III PI3K inactivation in concomitance with
altered kinetics of IR endocytic trafficking.
Insulin stimulates UVRAG-associated class III PI3K activity.
Since IR signalling is negatively regulated by class III PI3K,
we asked whether the activity of class III PI3K could be sensitive
to insulin. While an increase in cellular PI3P levels has
been reported, no significant changes in hVps34 activity on
insulin stimulation have been observed24,28,29. Recent reports
demonstrated that measurement of total class III PI3K activity
immunoprecipitated with anti-Vps34 antibody is not informative
as Vps15/Vps34 proteins are engaged in complexes with different
functions and regulation21. We measured class III PI3K
activity associated with ATG14 and UVRAG, two mutually
exclusive binding proteins of the core Vps34/Vps15 complex
(Supplementary Fig. 3a). In agreement with recent reports22 and
consistent with autophagy activation, Vps34 activity in ATG14
complex was significantly increased in response to amino-acid
withdrawal (Fig. 3a). At the same time, UVRAG-associated
Vps34 activity was insensitive to amino-acid deprivation (Fig. 3a).
To determine whether class III PI3K activity is regulated by
insulin, we analysed total Vps34 and UVRAG- or ATG14-
associated Vps34 lipid kinase activity in primary hepatocytes,
which were insulin starved and then stimulated for different
times. Consistent with earlier reports, total Vps34 activity was not
modified in response to insulin (Fig. 3b). Measurements of
ATG14-associated Vps34 lipid kinase activity revealed that in
contrast to amino-acid starvation, it was unchanged by insulin
stimulation. However, insulin stimulation resulted in twofold
increase of Vps34 activity in UVRAG-containing complexes
(Fig. 3b). In addition, co-immunoprecipitation studies revealed
that IR interacts with ectopically expressed Flag-tagged UVRAG
complexes (Fig. 3c). Further studies revealed that in primary
hepatocytes complex between endogenous IR and regulatory
subunits of class III PI3K, Vps15 and UVRAG was induced by
insulin stimulation (Fig. 3d and Supplementary Fig. 3c).
Immunoprecipitation experiments followed by class III PI3K
biochemical assay further confirmed that active Vps34 was
in complex with endogenous IR (Supplementary Fig. 3d).
Mechanistically, insulin stimulation of primary hepatocytes
resulted in dissociation of Rubicon, a negative regulator of
Vps34 activity in UVRAG-containing complexes (Fig. 3e).
Altogether, these data demonstrate that distinct class III PI3K
complexes are differently regulated in response to nutrient
starvation and insulin stimulation revealing unappreciated
crosstalk between IR signalling and class III PI3K activity
regulation.
Hepatic Vps15 depletion improves glucose metabolism. Next,
we sought to determine the consequences of class III PI3K
inactivation on IR signalling and metabolic homeostasis in vivo.
We recently demonstrated that Vps15 is an essential gene
product, as witnessed by the early embryonic lethality of whole
body Vps15 knockout mutants26. To circumvent the embryonic
lethality and to address the role of Vps15 in tissue insulin
response, hepatic Vps15 was targeted in vivo in adult mice by CRE
recombinase delivered through intravenous injection of
adenoviral vectors. The selectiveness of this approach to hepatic
tissue was evidenced by lack of Vps15 gene recombination
and unaffected Vps15 protein expression in other tissues
(Supplementary Fig. 4a,b). Effective depletion of hepatic Vps15
expression was confirmed both at transcript and protein levels
revealing an 80% decrease of Vps15 levels in CRE-expressing
livers (Supplementary Fig. 4c–e). Analysis of Vps15f/f mice 10
days postinjection revealed that adenoviral CRE-treated mice
developed liver hypertrophy (Fig. 4a and Supplementary Fig. 4f).
Liver hypertrophy of Vps15-depleted mice was due to increase in
hepatocyte cell size and cell number (Fig. 4b and Supplementary
Fig. 4g). In addition, hepatocytes in adenoviral CRE-transduced
livers developed striking vacuolization (Fig. 4b). In agreement
with the requirement of class III PI3K for autophagy, the acute
deletion of Vps15 resulted in autophagy block, as revealed by the
accumulation of an autophagy cargo receptor, p62/SQSTM1,
increased levels of the unconjugated form of LC3 (LC3-I) and a
reduction of lipidated LC3 (LC3-II) (Supplementary Fig. 4c).
Consistent with the data in cultured cells, hepatic Akt signalling
was activated in Vps15 mutant mice under refeeding conditions
(Supplementary Fig. 5a). Importantly, acute short-term hepatic
depletion of Vps15 affected whole-body glucose metabolism, as
adenoviral CRE-injected mice showed significant hypoglycaemia
in starvation conditions and in response to an intraperitoneal
glucose challenge (Fig. 4c). In sum, similarly to in vitro models,
short-term depletion of Vps15 in vivo potentiates insulin
signalling and impacts whole-body glucose metabolism.
Akt signalling is augmented in hepatic mutants of Vps15. Next,
we generated the liver-specific Vps15 knockout mice (herein
referred as Vps15 LKO). To obtain Vps15 LKO mice, the Vps15f/f
mice were crossed with transgenic line overexpressing CRE
under the mouse albumin enhancer/promoter. Alb-Cre drives
liver-specific CRE expression starting at E13.5 and achieves
efficient deletion of targeted gene at early postnatal stage both in
hepatocytes and biliary cells30. The loss of hepatic Vps15
expression was evidenced by transcript and protein analysis of
the livers of Vps15 LKO mice (Supplementary Fig. 6a,b). Vps15
LKO mice recapitulated the main features observed after
short-term Vps15 depletion by adenoviral CRE transduction:
hepatomegaly due to increased cell size and cell proliferation
(Supplementary Fig. 6c–e), vacuolization (Supplementary Fig. 6f)
and autophagy block witnessed by accumulation of p62,
LC3 (LC3-I/II) and polyubiquitinated proteins (Supplementary
Fig. 6b). Consistent with the observations in Hepa1.6 cells
(Fig. 2a–d and Supplementary Fig. 1d), the IR trafficking defects
in mutant hepatocytes were highlighted by the perturbations of
endolysosomal compartment and accumulation of endogenous IR
in Vps15-null hepatocytes (Supplementary Fig. 6g). Altogether,
Vps15 LKO recapitulates the autophagy and IR trafficking defects
observed both in vitro and in vivo on Vps15 depletion.
Importantly, increased hepatic insulin signalling was observed
in Vps15 LKO mice both in random-fed and on insulin challenge
conditions, as witnessed by Akt and FoxO1 phosphorylation
(Fig. 4d,e). Similarly to cell cultures, increased IR tyrosine
phosphorylation was detected in the liver extracts of Vps15
mutants compared with controls (Supplementary Fig. 7a). These
data were consistent with the improved insulin and glucose
tolerance after an intraperitoneal load observed in hepatic Vps15
LKO mice (Fig. 4f and Supplementary Fig. 7b). Interestingly,
despite the autophagy block the hepatic Vps15 mutant did not
present with steatosis as reported for other mouse models of
deficient autophagy14,31,32. On the contrary, the hepatic tissue
of mice after chronic (Supplementary Fig. 8a,b) or acute
(Supplementary Fig. 8e,f) Vps15 depletion was characterized by
significantly lower hepatic lipid content. This was accompanied
by decreased expression of lipogenic enzymes and marked
increase in expression of lipases (Supplementary Fig. 8c). In
addition, loss of hepatic Vps15 resulted in potent induction of
glycolytic enzyme expression both on transcript and protein
levels (Supplementary Fig. 9). The switch in expression of hepatic
isoforms of hexokinase and pyruvate kinase to HK2 and PKM2
was observed in the livers of Vps15 mutants (Supplementary
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Fig. 9). Given increased hepatic insulin signalling and striking
rearrangements in the expression of metabolic enzymes observed
on hepatic Vps15 depletion, we compared the metabolic rates of
age matched controls and Vps15 LKO mice. Vps15 LKO mice
compared with littermate controls showed consistently higher
oxygen consumption and energy expenditure in course of
measurement (Supplementary Fig. 10a,b). This was accompanied
by significantly augmented respiratory exchange ratio in Vps15
knockouts compared with controls suggesting the preferable
utilization of carbohydrates as an energy source (Supplementary
Fig. 10c). In addition, we did not observe significant difference in
cumulative food or drink intake between experimental groups
(Supplementary Fig. 10d). The increased metabolic activity of
hepatic Vps15 mutants was most evident during the light phase of
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Figure 3 | UVRAG-associated class III lipid kinase is activated by insulin. (a) ATG14- and UVRAG-containing Vps34 complexes were
immunoprecipitated from Hepa1.6 cells grown in the presence (NR) or absence of amino acids (AA) and assayed for lipid kinase activity. Inputs for each
assay were immunoblotted to determine the amounts of the Vps34 co-immunoprecipitated. PI3P signals were densitometrically measured and normalized
to Vps34 protein levels. The data are presented as a fold difference of PI3P normalized to co-immunoprecipitated Vps34 levels revealed by immunoblot for
each condition. Data are means±s.e.m. (n¼4, *Po0.05 versus NR, two-tailed, unpaired Student’s t-test). (b) ATG14- and UVRAG-containing Vps34
complexes were immunoprecipitated from primary hepatocytes, which were serum starved for 24 h followed by stimulation with 1 mM insulin (Ins) and
assayed for lipid kinase activity. PI3P signals were densitometrically measured. The data are presented as a fold difference of PI3P normalized to
co-immunoprecipitated Vps34 levels revealed by immunoblot for each condition. Data are means±s.e.m. (n¼ 3, *Po0.05 versus starved cells, two-tailed,
unpaired Student’s t-test). Representative immunoblot analyses of ATG14, UVRAG and Vps34 co-immunoprecipitates are presented as Supplementary
Fig. 3a and Supplementary Fig. 3b. (c) Primary hepatocytes were transiently transfected with UVRAG–Flag cDNA-expressing vector 12 h post-plating and
were kept in the serum containing media. The 36-h post-transfection cells were collected and UVRAG–Flag complexes were immunoprecipitated with
anti-Flag antibody. The presence of IRb and class III PI3K subunits in the immunoprecipitation eluates was revealed by immunoblot. (d) Endogenous IRb
was immunoprecipitated from primary hepatocytes, which were serum starved for 24 h and stimulated with 1 mM insulin. The presence of Vps15 and IRb in
the immunoprecipitation eluates was revealed by immunoblot. Densitometric analyses of co-immunoprecipitated endogenous Vps15 normalized to IRb are
presented as fold difference over the unstimulated condition. Data are means±s.e.m. (n¼ 3, *Po0.05 versus starved cells, two-tailed, unpaired Student’s
t-test). (e) UVRAG-containing complexes were immunoprecipitated from primary hepatocytes, which were serum starved for 24 h followed by stimulation
with 1mM insulin for indicated times. Immunoprecipitated endogenous class III PI3K subunits were revealed by immunoblotting. Densitometric analyses
of co-immunoprecipitated endogenous Rubicon normalized to UVRAG are presented as fold difference over the unstimulated condition. Data are
means±s.e.m. (n¼ 3, *Po0.05 versus starved cells, two-tailed, unpaired Student’s t-test). The protein G beads served as a control of the nonspecific
binding in c–e.
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Figure 4 | Increased insulin action in Vps15 hepatic mutants. (a) Liver weight to body weight ratio of random-fed Vps15f/f mice 10 days post-transduction
with Adeno-GFP or Adeno-CRE vectors. Data are means±s.e.m. (n¼ 5–6, *Po0.05: versus Adeno-GFP, two-tailed, unpaired Student’s t-test).
(b) H&E-stained liver sections of random-fed Vps15f/f mice 10 days post-transduction with Adeno-GFP or Adeno-CRE vectors showing marked
vacuolization of hepatocytes in livers of Adeno-CRE-transduced mice. Scale bar, 100mm. (c) Intraperitoneal GTT in overnight fasted Vps15f/f mice 7 days
post-transduction with Adeno-GFP or Adeno-CRE vectors. The histogram of the average value of the area under the respective curve calculated with
GraphPadPrizm5 software is presented. Data are means±s.e.m. (n¼ 5–6, *Po0.05 versus Adeno-GFP, two-tailed, unpaired Student’s t-test).
(d) Immunoblot analysis of total protein liver extracts of random-fed 2-month-old Vps15f/f and AlbCreþ ;Vps15f/f using indicated antibodies. Densitometric
analyses of phosphoprotein levels normalized to total protein presented as folds over Vps15f/f. Data are means±s.e.m. (n¼4–5, *Po0.05 versus Vps15f/f,
two-tailed, unpaired Student’s t-test). (e) Immunoblot analysis of total protein liver extracts of starved for 12 h or starved for 12 h followed by injection of
insulin 2-month-old Vps15f/f and AlbCreþ ;Vps15f/f mice. Densitometric analyses of phosphoprotein levels normalized to total protein presented as folds
over starved Vps15f/f. Data are means±s.e.m. (n¼ 3, *Po0.05: versus Vps15f/f, two-tailed, unpaired Student’s t-test). (f) Intraperitoneal insulin tolerance
test performed on starved for 6 h 6-week-old Vps15f/f and AlbCreþ ;Vps15f/f mice. The histogram of an average value of the area under the respective curve
was calculated with GraphPadPrizm5 software. Data are means±s.e.m. (n¼8–14, *Po0.05 versus Vps15f/f, two-tailed, unpaired Student’s t-test).
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the cycle, which is in agreement with the increased activity of
Vps15 mutant mice observed (Supplementary Fig. 10e).
The ameliorated metabolic parameters of Vps15 LKOs were
further observed under nutrient challenge, where Vps15 control
and mutant mice were submitted to 2-week long high-fat diet
(HFD) regimen. As expected, after 2 weeks of HFD, the control
mice developed significant glucose intolerance (Supplementary
Fig. 7b). Remarkably, hepatic Vps15 mutants, unlike controls,
were protected from deleterious metabolic effect of HFD
(Supplementary Fig. 7b). Improved insulin sensitivity on hepatic
Vps15 loss was also accompanied by significantly lower circulat-
ing levels of insulin both on chow and HFD in random-fed Vps15
LKO mice (Supplementary Fig. 7c).
Earlier studies addressed the causative link between the
impaired autophagic flux and insulin resistance14. The study by
Yang et al.14 demonstrated that the metabolic phenotype of ob/ob
mice could be improved by increasing autophagic flux through
ATG7 overexpression. In a somewhat contradictory fashion,
recent work by Kim et al. suggested that the block of autophagy
flux in Atg7 skeletal muscle or liver mutants led to endoplasmic
reticulum (ER) stress and resulted in activation of ATF4
transcription factor responses, leading to the induction of Fgf21
and protection of mice from the detrimental effects of HFD
feeding13. In Vps15 LKO mice, we did not observe induction of
hepatic Fgf21 mRNA expression (Supplementary Fig. 7d).
In addition, Fgf21 levels measured in plasma of control and
Vps15 LKO mice did not reveal significant differences between
two genotypes in random-fed or in starved conditions
(Supplementary Fig. 7e).
Defective gluconeogenesis in Vps15 mutants. The suppression
of gluconeogenesis is a major hypoglycaemic action of insulin in
liver. To elucidate the mechanisms of improved glucose tolerance
in Vps15 LKO, the expression of gluconeogenic enzymes was
determined. Expression of key gluconeogenic enzymes was
severely suppressed in both models of Vps15 deficiency, in Vps15
LKO mice (Fig. 5a,b) and after short-term depletion by adeno-
viral CRE transduction (Supplementary Fig. 11a,b). Furthermore,
the expression of peroxisome proliferator-activated receptor
gamma coactivator 1 alpha (PGC1a), a transcriptional coactivator
that is essential for the expression of genes of the gluconeogenesis
pathway, was significantly downregulated in the livers of floxed
mice injected with Adeno-CRE vectors (Supplementary Fig. 5b).
In addition, hepatic expression of PGC1a as well as the
gluconeogenic enzymes was inhibited even in starved mice and to
great extent resistant to refeeding after Vps15 depletion
(Supplementary Fig. 5b). Functionally, pyruvate tolerance test in
Vps15 LKO mice revealed a profound defect in glucose produc-
tion in response to a pyruvate challenge (Fig. 5c). Next,
to confirm the effects of class III PI3K inactivation on glucose
metabolism in a cell autonomous model, Vps15 was depleted in
primary hepatocytes using adenoviral vectors expressing shRNA.
As shown in Fig. 5d,e, Vps15 knockdown in primary wild-type
hepatocytes significantly reduced expression of rate-limiting
enzymes in the gluconeogenesis pathway, including G6PC and
PEPCK. The later effect could be rescued by concomitant over-
expression of shRNA-resistant hVps15 (Supplementary Fig. 11c).
Notably, the acute depletion of Vps15 in primary hepatocytes was
sufficient to inhibit gluconeogenesis, as evidenced by the drop in
glucose release in response to pyruvate/lactate addition (Fig. 5f).
Thus, interference with Vps15 expression in vitro and in vivo is
associated with impaired gluconeogenesis.
The striking defect in gluconeogenic gene expression in Vps15
mutants phenocopies the changes in the hepatic metabolism
observed in FoxO1 LKO mice33,34. FoxO1 is a master regulator of
carbohydrate metabolism by positively controlling the expression
of key gluconeogenesis enzymes G6PC and PEPCK34,35.
Consistently, transcriptional activity of FoxO1 is under negative
control of insulin receptor signalling via Akt-mediated
phosphorylation36. FoxO1 phosphorylation by Akt promotes its
interaction with 14-3-3 proteins, nuclear exclusion and cytosolic
degradation by the proteasome37,38. In line with the increased
stability of IR, Akt activation and increased FoxO1
phosphorylation observed in hepatic Vps15 mutants, FoxO1
levels were markedly decreased, while the interaction with 14-3-3
proteins was maintained in Vps15-depleted hepatocytes (Fig. 6a).
Furthermore, FoxO1 protein levels in Vps15-depleted hepatocytes
were partly rescued by treatment with the proteasome inhibitor
MG132, suggesting an active proteasomal degradation of FoxO1
protein in mutant hepatocytes (Fig. 6b). Notably, a predominant
cytoplasmic localization of FoxO1 was observed in Vps15 mutant
hepatocytes by fractionation and immunofluorescence experiments
(Fig. 6c,d). These results demonstrate that class III PI3K activity
has a cell autonomous role in insulin signal transduction, FoxO1-
dependent transcription and gluconeogenic programme.
Improved Akt signalling on Vps15 depletion requires IR. The
improved metabolic profile of Vps15 mutants prompted us to test
the therapeutic benefits of Vps15 targeting in the models of
metabolic challenge and insulin resistance. As a proof of concept,
we first tested whether acute depletion of Vps15 ameliorated
glucose metabolism of HFD-challenged mice. To this end, the
Vps15f/f mice were subjected to short-term HFD feeding protocol
and the glucose tolerance test (GTT) was performed 2 weeks later
(Fig. 7a). Mice were then assigned to two experimental groups,
which were injected either with CRE- or GFP-expressing
adenoviral vectors. Five days postinjection mice were subjected to
the GTT challenge. Unlike Adeno-GFP-treated mice, acute
short-term depletion of hepatic Vps15 significantly ameliorated
the glucose tolerance of HFD-fed Vps15f/f mice (Fig. 7a). Next,
we asked whether the metabolic improvement on hepatic Vps15
inactivation was dependent on functional IR. To this end, we used
a mouse model of inducible hepatocyte-specific depletion of IR,
iLIRKO mutants. Two months after inducing the CRE-mediated
recombination, iLIRKO mice developed significant glucose
intolerance (Fig. 7b). Importantly, short-term Vps15 depletion
using shRNA-expressing adenoviral vectors improved glucose
tolerance in control, but not in hepatic IR mutants (Fig. 7b).
Further molecular analysis in primary hepatocyte cultures of
control and iLIRKO mice revealed that loss of IR expression
precluded activation of Akt signalling by Vps15 downregulation
(Fig. 7c). To rule out any chronic adaptation to hepatic IR loss,
we also assayed the effect of Vps15 downregulation in the
IR-depleted hepatocytes by transduction with Adeno-CRE vectors
(Supplementary Fig. 12). Similarly to the cultures prepared from
iLIRKO mice, the acute loss of IR impeded the Akt stimulation by
Vps15 depletion (Supplementary Fig. 12).
To extend our observations on the effects of Vps15 inactivation
on IR/Akt signalling, we used an additional model of insulin
resistance. Previous works demonstrated that loss of tumour
suppressor tuberous sclerosis complex 2 (TSC2) gene leads to
insulin resistance due to reduction in Akt phosphorylation39. The
latter is ascribed to mTORC1-dependent negative feedback
mechanisms and the defects in mTORC2 activation39,40. The
expression of IRb was strikingly downregulated in TSC2-null cells,
suggesting additional mechanism of regulation (Fig. 7d).
Importantly, unlike IGF1R, IRb levels could be rescued by
depletion of Vps15 in TSC2-deficient mouse embryonic
fibroblasts (MEFs) (Fig. 7d). Normalization of IRb levels was
paralleled by increase in Akt phosphorylation (Fig. 7d).
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Significantly, the depletion of Vps15 in TSC2-null MEFs improved
insulin-stimulated Akt activation and phosphorylation of its
downstream target—Pras40 (Fig. 7e). In sum, the increase of Akt
signalling on Vps15 depletion is IR dependent and may rescue the
defect in the model of IR resistance due to TSC2 inactivation.
Metabolic amelioration on acute Vps15 inactivation in vivo. To
further test whether the Vps15 depletion could have therapeutic
benefits in vivo in animal models of diabetes and insulin
resistance, the ob/ob mice were injected with adenoviral vectors
expressing shRNA against Vps15. One week after injection, the
body weight, liver and peripheral organ weight were not modified
by the treatment (Supplementary Fig. 13a). Importantly, this
treatment led to a 70% and a 50% decrease in hepatic Vps15
transcript and protein levels, respectively (Supplementary
Fig. 13b,c). At the same time, the expression of Vps15 in WAT
and muscle tissues was unmodified (Supplementary Fig. 13d).
Downregulation of hepatic Vps15 was accompanied by impaired
autophagic processing of LC3 and accumulation of p62 in the
livers of shRNA Vps15-treated mice (Supplementary Fig. 13c,e).
Remarkably, hepatic downregulation of Vps15 significantly
improved glucose tolerance of ob/ob mice (Fig. 8a,b). This was
accompanied by a decrease in liver steatosis on Vps15 depletion
(Fig. 8c). The plasma metabolite levels were not modified by the
treatment (Supplementary Fig. 14a). The decrease in hepatic
triglyceride levels was accompanied by reduction of lipogenic
transcription activators and lipogenic enzyme expression
(Supplementary Fig. 14b,c). The expression of the lipases was
induced in the livers of ob/ob mice on Vps15 depletion suggesting
the induction of lipolysis (Supplementary Fig. 14b). Expression of
PGC1a transcriptional coactivator was significantly decreased
(Supplementary Fig. 14b). The expression of glycolytic enzymes
HK2 and PKM2 was markedly induced (Supplementary Fig. 14c).
Similarly, hepatic Vps15 downregulation reverted glucose
intolerance in wild-type mice fed for short term with HFD
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Figure 5 | Gluconeogenesis is impaired in hepatic Vps15 mutants. (a) Relative mRNA expression levels of genes implicated in gluconeogenesis in the
livers of 1-month-old random-fed Vps15f/f and AlbCreþ ;Vps15f/f mice. Data are means±s.e.m. (n¼ 5–8, *Po0.05 versus Vps15f/f, two-tailed, unpaired
Student’s t-test). (b) Immunoblot analysis of total protein liver extracts of random-fed 1-month-old Vps15f/f and AlbCreþ ;Vps15f/f using G6PC antibody.
Immunoblot with anti-tubulin antibody served as loading control. (c) Intraperitoneal pyruvate tolerance test performed on overnight-starved 6-week-old
Vps15f/f and AlbCreþ ;Vps15f/f mice (n¼ 5–8, *Po0.05 versus Vps15f/f, two-tailed, unpaired Student’s t-test). The histogram of an average value of the
area under the respective curve was calculated with GraphPadPrizm5 software (n¼ 5–8, *Po0.05 versus Vps15f/f, two-tailed, unpaired Student’s t-test).
(d) Immunoblot analyses of cell extracts of primary hepatocytes transduced with Adeno-shRNA SCR or Adeno-shRNA Vps15 vectors with indicated
antibodies. Primary hepatocytes were transduced and cells were collected 48 h postinfection for further analysis. Immunoblot with anti-tubulin antibody
served as a loading control. (e) Relative mRNA expression levels of gluconeogenic enzymes in primary hepatocytes transduced with Adeno-shRNA SCR or
Adeno-shRNA Vps15 vectors. Cells were collected 48 h postinfection. Data are means±s.e.m. (n¼ 3, *Po0.05 versus shRNA SCR infected, two-tailed,
unpaired Student’s t-test). (f) Glucose production by primary hepatocytes transduced with Adeno-shRNA SCR or Adeno-shRNA Vps15 vectors. Primary
hepatocytes 48 h postinfection were incubated for 12 h in glucose-free DMEM containing lactate/pyruvate (10:1mM). Glucose content in the media was
assayed enzymatically and normalized to protein content. Data are means±s.e.m. (n¼ 6, *Po0.05 versus shRNA SCR infected, two-tailed, unpaired
Student’s t-test).
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(Supplementary Fig. 14d). Altogether, the acute depletion of
Vps15 in livers improves the metabolic parameters in genetic and
diet-induced animal models.
Vps15 depletion improves hepatic IR signalling in ob/ob mice.
In line with our earlier observations, shRNA silencing of hepatic
Vps15 in obese mice resulted in a sharp activation of Akt
as evidenced by Ser473 and Thr308 phosphorylation (Fig. 8d).
The activation of the pathway was further corroborated by a
significant increase in the phosphorylation of Akt substrates—
Pras40 and FoxO1 (Fig. 8d). The phosphorylation of Akt
substrates was not modified in muscles and fat tissue of treated
mice (Supplementary Fig. 13d). In addition, immunoprecipitation
analyses with anti-IRb antibody revealed that p85aPI3K was
more abundant in the complexes precipitated from the extracts of
livers of shRNA Vps15-treated mice as compared with controls
(Fig. 8e). Finally, we asked whether IR localization is affected in
shRNA Vps15-transduced mice. Microscopic examination of
liver sections of shVps15-treated mice revealed marked increase
in IRb-positive endosomes (Fig. 8f). Taken together, our
data suggest that selective inhibition of hepatic class III PI3K
may have beneficial consequences in conditions of T2D and
metabolic syndrome, by ameliorating glucose metabolism
through improved IR signalling.
Discussion
In this study we provide experimental evidence that class III PI3K
is regulated by insulin in hepatocytes and in turn modulates IR
signalling to insure whole-body metabolic responses. We show
that UVRAG-associated class III PI3K interacts with IR and is
activated by insulin, with kinetics that are consistent with a role in
IR endocytosis and trafficking. Interference with the expression of
the regulatory subunit in the class III PI3K complex, Vps15,
results in three novel and yet unreported outcomes: (i) defects of
IR degradation and increased Akt signalling accompanied by
profound perturbations in endocytic trafficking; (ii) blunted
gluconeogenesis concomitant with nuclear exclusion of FoxO1
transcription factor and defects in FoxO1-dependent gene
expression; and (iii) amelioration of metabolic syndromes in
genetic and diet-induced animal models. These data reveal a
previously unappreciated role of class III PI3K in the control of
insulin sensitivity and metabolic adaptations.
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800mg of total protein extracts of control or Vps15-depleted primary hepatocytes, which were collected 72 h post-transduction with Adeno-GFP or Adeno-
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(right panel). (b) FoxO1 protein levels could be partially rescued by MG132 treatment of Vps15-depleted hepatocytes. After 72 h of transduction with
Adeno-GFP or Adeno-CRE vectors hepatocytes were treated with 10mM MG132 for 1 h before collected for further analysis. Immunoblot analysis of FoxO1
protein levels is presented. Immunoblot with anti-actin antibody serves as a loading control. Densitometric analyses of actin-normalized FoxO1 protein
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cross-contamination of cytoplasmic and nuclear fractions, respectively. (d) Immunofluorescent analyses of FoxO1 subcellular localization in control and
Vps15-depleted primary hepatocytes 72 h post-transduction with Adeno-GFP or Adeno-CRE vectors. Before fixation cells were either stimulated with1 mM
insulin for 30min or kept untreated in media without serum. Cells were PFA fixed and stained with anti-FoxO1 antibody, secondary anti-rabbit IgG Alexa
Fluor 565 antibody was used for detection (images presented in green pseudocolour). Scale bar, 20mm.
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How class III PI3K activity is regulated by extracellular signals
has been a long-standing question in the field. Insulin, glucose
and amino-acid levels that effectively modulate endocytosis and
autophagy, have deceivingly modest effects on total Vps34 lipid
kinase activity22,24,41. An explanation has recently came from the
demonstration that glucose and amino-acid starvation stimulate
specific Vps34-containing complexes without having a significant
effect on the total Vps34 activity in some cells22,23. However, the
effect of insulin on specific complexes has never been tested.
In the present study we show that, while amino-acid starvation
potently induces ATG14-containing class III PI3K activity,
insulin stimulation selectively promotes the activity of UVRAG-
containing class III PI3K (Fig. 3). Importantly, this evidence
provides a regulatory mechanism for the reported functions of
these distinct complexes, that is, the induction of autophagy
during nutrient starvation by the ATG14-containing complex and
the promotion of endocytic trafficking during growth factor
stimulation by the UVRAG-containing complex. How insulin
specifically stimulates UVRAG-containing complexes will require
further investigation. Interestingly, we show that IR is found in
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measured at indicated times. Data are means±s.e.m. (n¼ 6–9, *Po0.05 versus Adeno-GFP, two-tailed, unpaired Student’s t-test). (c) Primary
hepatocytes prepared from control or iLIRKO mutant mice were transduced with Adeno-GFP or Adeno-shRNAVps15 vectors. The 24-h post-transduction
cells were starved and then stimulated with 1 mM insulin (Ins) for 1 h. Activation of IR-signalling pathway was revealed by immunoblot analysis.
(d) Immortalized TSC2 / ;p53 / and control TSC2þ /þ ;p53 / MEFs were transduced with Adeno-GFP or Adeno-shRNAVps15 vectors. Cells were
kept in the media in presence of 10% serum and were collected for analysis 24 h postinfection. Total protein extracts were analysed by immunoblotting.
(e) Immortalized TSC2 / ;p53 / and control TSC2þ /þ ;p53 / MEFs were transduced with Adeno-GFP or Adeno-shRNAVps15 vectors. The 24-h
postinfection cells were serum starved for 24 h followed by stimulation with 1 mM insulin for indicated times. Total protein extracts were analysed by
immunoblotting with indicated antibodies. Immunoblot with anti-actin antibody served as a loading control.
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Figure 8 | Depletion of hepatic Vps15 improves metabolic phenotype of ob/ob mice. (a) Intraperitoneal GTT in overnight-starved ob/ob mice 7 days
post-transduction with Adeno-shRNA SCR or Adeno-shRNA Vps15 vectors. Mice were injected with 1 g kg 1 of glucose and glycaemia measured at
indicated times. Data are means±s.e.m. (n¼4–6, *Po0.05 versus Adeno-shRNA SCR, two-tailed, unpaired Student’s t-test). (b) The histogram of an
average value of the area under the respective curve presented in a was calculated with GraphPadPrizm5 software. Data are means±s.e.m. (n¼4–6,
*Po0.05 versus Adeno-shRNA SCR, two-tailed, unpaired Student’s t-test). (c) Oil red staining of frozen liver sections of random-fed ob/ob mice killed
8 days post-transduction with Adeno-shRNA SCR or Adeno-shRNA Vps15 vectors (left panel), scale bar, 50mm. Triglyceride (TG) content measured
enzymatically in livers of random-fed ob/ob mice 8 days post-transduction with Adeno-shRNA SCR or Adeno-shRNAVps15 vectors (right panel). Data are
means±s.e.m. (n¼4–6, *Po0.05 versus Adeno-shRNA SCR, two-tailed, unpaired Student’s t-test). (d) Immunoblot analyses of liver extracts from
random-fed ob/ob mice 8 days post-transduction with Adeno-shRNA SCR or Adeno-shRNA Vps15 vectors. Densitometric analyses of phosphoprotein
levels normalized to total protein levels presented as folds over shRNA SCR. Data are means±s.e.m. (n¼4–5, *Po0.05 versus Adeno-shRNA, two-tailed,
unpaired Student’s t-test). (e) Immunoblot analyses of p85aPI3K immunoprecipitated in complex with IRb. IRb was immunoprecipitated with anti-IRb
antibody from liver total protein extracts of random-fed ob/ob mice sacrificed 8 days post-transduction with Adeno-shRNA SCR or Adeno-shRNA Vps15
vectors. Densitometric analysis of p85aPI3K normalized to immunoprecipitated IRb protein levels is presented. Data are means±s.e.m. (n¼ 3–6, *Po0.05
versus Adeno-shRNA SCR). (f) Immunofluorescence analyses of formalin-fixed paraffin-embedded liver sections from random-fed ob/ob mice 8 days
post-transduction with Adeno-shRNA SCR or Adeno-shRNAVps15 vectors with anti-IRb antibody. Secondary anti-rabbit IgG Alexa Fluor 565 antibody was
used for detection (images presented in green pseudocolour). Scale bar, 10mm.
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complex with class III PI3K (Fig. 3c,d and Supplementary
Fig. 3c). Bioinformatic analysis by online resource ScanSite3
(ref. 42) suggests the presence in UVRAG and Vps15 of putative
SH2-binding domains that recognize phospho-tyrosine. In
addition, both UVRAG and Vps15 are identified as tyrosine
phosphorylated proteins in independent phosphoproteome
studies including those accessible in Phosphosite database43.
It is therefore possible a direct action of IR/IRS on UVRAG-
containing class III PI3K complexes, similar to the known effect
on class I PI3K. Consistently, another component of class III
PI3K complex, Beclin-1, has been recently reported to be tyrosine
phosphorylated by epidermal growth factor receptor, resulting in
inhibition of Vps34 activity44. However, we cannot exclude
intermediate steps, possibly involving the Rab family of small
GTPases, which are also actively involved in endosomal
trafficking and found in complex with class III PI3K45–47. Of
note, Rab5 has been shown to co-localize with IR in endosomes
and its GTP loading is potently stimulated by insulin48. In
addition, Rab7 can interact with class III PI3K complexes and
stimulate its activity45,49. Therefore, the crosstalk between IR-
Rab5/Rab7-Vps34/Vps15/UVRAG is likely to exist at distinct
levels in insulin-stimulated cells.
We demonstrate that depletion of Vps15 increases insulin
sensitivity in different models both in vitro and in vivo (Figs 1,4,7
and 8). This suggests that Vps34/Vps15 complex is involved in a
feedback regulatory loop that, on insulin stimulation, contributes
to the modulation of IR function. The effects of class III PI3K
inactivation are complex. At current stage, it is difficult to
separate the general trafficking defect due to PI3P depletion from
potential novel direct mechanisms of class III PI3K on IR
function. However, it is likely that the IR-signalling perturbations
we observed on Vps15 depletion are due to compromised
endocytic trafficking of the receptor. The reduced velocity of
IR-positive endosomes (Fig. 2b,c and Supplementary Movie)
together with the striking reorganization of the endosomal
compartment (Figs 1d and 2a and Supplementary Figs 1d, 2d
and 6g) suggest that trafficking defects might largely contribute to
the delayed receptor degradation. In these conditions, prolonged
residence of IR in endosomes would contribute to the amplified
insulin signalling that we measured. Indeed, key insulin signal
transduction elements are found at endosomal membranes
including IRS, class I PI3K and Akt7. Accordingly, preventing
IR degradation by blocking its intracellular transport resulted in
similar increase in insulin-dependent signalling (Fig. 2d). Of note,
an endosomal protein, APPL1, has been reported to favour
downstream insulin signalling through the Akt pathway50,51.
APPL1 was identified in protein interaction screens as a binding
partner of Akt and an adaptor protein positively regulating Akt
activity52–54. It has been shown to favour the recruitment of IRS
proteins to the IR and to release Akt from the binding to TRB3,
its endogenous inhibitor50,51. Consistently, in vivo studies using
gain- or loss-of-function approaches have confirmed the positive
role of APPL1 on insulin sensitivity50,51. Interestingly, PI3P is
required for the maturation of APPL1-positive endosomes to
sorting endosomes54. It would be interesting to test whether
loss of functional class III PI3K affects APPL1þ endosomes
contributing to the observed metabolic responses.
In addition, it is plausible that the endosomal sorting and
lysosomal degrading activities are lower in Vps15-depleted livers,
partly accounting for the slower kinetics of IR downregulation
after insulin stimulation. In a previous study on skeletal muscles,
we have shown that the lysosomal function is affected by the
Vps15 depletion due to sorting defects of proteolytic enzymes26.
Of note, chloroquine, a drug that interferes with the acidification
of the endosomes, prevents dissociation of insulin from its
receptor and subsequent receptor degradation, also potentiates
insulin action and has beneficial effects on glucose
homeostasis6,55–57.
Massive vacuolation is a characteristic morphological change in
the cells depleted of Vps15 apparent both in vitro and in vivo.
Despite highly resembling the steatosis, the histological analyses
by Oil Red and Bodipy staining did not reveal apparent
accumulation of neutral lipids in hepatic tissue neither on acute
or chronic Vps15 depletion. Furthermore, the acute Vps15
downregulation in the livers of obese mice decreased triglyceride
levels. At first sight, those are unexpected observations as hepatic
inactivation of essential autophagic genes, Atg5 and Atg7, was
reported to induce steatosis due to defective lipophagy14,31,32.
However, we cannot exclude that other types of lipids that could
not be revealed by the analyses performed (for example, polar
lipids, including sphingolipids, phospholipids and ceramides)
accumulate on Vps15 depletion. This is in line with the
observations of increased phospholipid content on chronic
chloroquine treatment, which provoke cytoplasmic vacuolation
in different cell types including hepatocytes58. In addition,
the vacuolation of hepatocytes could be a morphological
manifestation of cytoplasmic accumulations of various sub-
stances, including water and glycogen, all having similar
morphology. Those structures could originate from different
membranes including plasma membrane, endosomal com-
partment, Golgi apparatus, lysosomes or autophagolysosomes at
the different stages of the maturation. The subcellular origin and
the content of abundant vacuolar structures in Vps15-depleted
cells require further studies. From the other hand, the
relationship between defective autophagy and the steatosis as
well as steatosis and insulin resistance are not completely
understood. Of note, increased insulin sensitivity of hepatocyte-
specific PTEN mouse mutants is accompanied by severe steatosis
and defective autophagy59,60. In contrast, hepatic mutants of
TSC1, which are characterized by severe autophagy block and
insulin resistance, are protected from diet-induced steatosis61,62.
Considering that class III PI3K controls both autophagy and
endocytic trafficking, the effects of its inactivation will be
manifested on multiple levels.
The role of FoxO1 transcription factor as a chief
regulator of gluconeogenic responses in the liver is firmly
established33–35,63,64. In addition, interference with FoxO1
activity or expression in mouse models of obesity or insulin
resistance significantly improves glucose tolerance35,63,64. These
observations are highly reminiscent of the Vps15 LKO mouse
phenotype (Figs 4,5,7 and 8 and Supplementary Figs 7 and 14).
Similarly to therapy with Foxo1 antisense oligonucleotides in
DIO mice35, depletion of Vps15 in ob/ob mice improves steatosis
and glucose metabolism (Fig. 8a–c). The best documented point
of control of FoxO1 is Akt-dependent phosphorylation and
inactivation in response to insulin36. In line with blunted
gluconeogenesis observed in Vps15-depleted hepatocytes and
in vivo, we detect increased phosphorylation of FoxO1 on Vps15
inactivation. Our observations in Vps15 LKO mice (Figs 4–6)
are in agreement with the established mechanism of IR/Akt-
dependent FoxO1 phosphorylation, leading to nuclear exclusion
and proteasomal degradation37,38. However, we cannot rule out
the possibility that the striking suppression of FoxO1 function in
Vps15-depleted hepatocytes is also the consequence of a direct
action of class III PI3K on FoxO1.
The central role of endocytic and autophagic trafficking in
nutrient/growth factor sensing and homeostasis has prompted
numerous studies on the metabolic consequences of their
functional alterations. The physiological importance of autophagy
for the maintenance of glycaemia during the perinatal period
before lactation is illustrated by the perinatal lethality of the
mouse autophagy mutants31,65. Defective autophagy is discussed
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both as a causative factor as well as accompanying state in many
pathological conditions10. Mouse models of obesity display
autophagy defects and the metabolic syndrome could be
improved by increasing autophagic flux through Atg7
overexpression or by autophagy enhancers14,15. However, a
defect in autophagic flux in skeletal muscles or liver by Atg7
deletion may also lead to increased circulating levels of Fgf21 and
protect from the detrimental effects of HFD feeding13.
Here we show that in vivo hepatic depletion of Vps15
has strikingly different outcomes on whole-body nutrient
homeostasis as compared with autophagy mutants. Despite the
involvement of class III PI3K in autophagy, the metabolic effects
of hepatic Vps15 depletion can be ascribed to a prominent role on
IR endocytic trafficking and signal transduction through the
alteration of a retrograde signalling mechanism. Defects of IR
endocytosis trafficking and degradation are reported in metabolic
conditions accompanied by hyperinsulinemia, such as genetic
forms of obesity and T2D11,12,66. Our data reveal the impact of
altering Vps34/Vps15 function in metabolic syndromes and
suggest a novel therapeutic target in these diseases.
Methods
Reagents. The following primary antibodies were used: Vps15 (1:1,000, Abnova,
H00030849-M03; or 1:1,000, Genetex, GTX108953); p62 (SQSTM) (1:3,000,
Abnova, H00008878-M01); Tubulin (1:5,000, Sigma, T9026); b-actin (1:50,000,
Sigma, A5316); Beclin-1 (1:1,000, Cell Signaling, 3495); pSer473 Akt (1:1,000, Cell
Signaling, 9275); pThr308 Akt (1:1,000, Cell Signaling, 9275); Akt (1:1,000, Cell
Signaling, 9272); pThr246 Pras40 (1:1,000, Cell Signaling, 2997); Pras40 (1:1,000,
Cell Signaling, 2691); GAPDH (1:1,000, Santa Cruz, SC-25778); pY IRb (1:1,000,
Cell Signaling, 3024 and 3021); Rab5 (1:1,000, Cell Signaling, 3547); Rubicon
(1:1,000, Cell Signaling, 8465); pThr24/32 FoxO1/3a (1:1,000, Cell Signaling, 9464);
pSer256 FoxO1 (1:1,000, Cell Signaling, 9461); FoxO1 (1:1,000, Cell Signaling,
2880); Lamin A/C (1:1,000, Cell Signaling, 2032); GST (1:5,000, Santa Cruz,
SC-459); IGF1R (1:1,000, Cell Signaling, 9750); p85a PI3K (1:1,000, Santa Cruz,
SC-423); IRS1 (1:500, Millipore, 06-248); UVRAG (1:1,000, Cell Signaling, 13115);
Atg14 (1:1,000, Cell Signaling, 5504); Vps34 (1:1,000, Cell Signaling, 4263); LC3
(1:1,000, NanoTools, 0231-100/LC3-3-5-5F10); Ub (1:1,000, Cell Signaling, 3963);
FAS (1:1,000, Cell Signaling, 3180); ATPCL (1:1,000, Cell Signaling, 4332); HK2
(1:1,000, Cell Signaling, 2867); PKM2 (1:1,000, Cell Signaling, 4053); Enolase
(1:1,000, Santa Cruz, SC-7455); PPARg (1:1,000, Cell Signaling, 2435); ACC
(1:1,000, Cell Signaling, 3662); Flag-tag (1:1,000, Sigma, F3162); LAMP1 (1:1,000,
Abcam, ab24170); LAMP2 (1:1,000, Abcam, ab13524); BrdU (1:500, Roche,
11170376001); b-catenin (1:500, BD Biosciences, 610153); VDAC (1:1,000,
Calbiochem, AB10527); G6PC (1:1,000, Santa Cruz, SC-33839 and a kind gift of
Gilles Mithieux (INSERM U855, France)); PEPCK (1:1,000, Santa Cruz, SC-32879);
and IRb (1:1,000, Santa Cruz, SC-711). For class III PI3K in vitro activity
antibodies were from MBL International ATG14 (PD026) and UVRAG (M160-3).
Vps34 antibody used for class III PI3K in vitro activity was from Echelon
Biosciences (Z-R015). GFP and GFP-CRE adenoviral vectors were described
previously26. Adenoviral vector expressing shRNA Vps15 was generated and
amplified by VectorBiolabs (USA). Adenovirus expressing shRNA Scrambled was
kindly provided by Stephan Herzig (Institute for Diabetes and Cancer, Germany).
2xFYVE-GFP-expressing vector was kindly provided by Sharon Tooze (CRUK,
UK). hIRb-RFP-overexpressing vector was kindly provided by Ingo B. Leibiger
(Karolinska Institutet, Sweden).
Animals. The Vsp15 conditional mutant mouse line was established at the
MCI/ICS (Mouse Clinical Institute—Institute Clinique de la Souris, Illkirch,
France) as described in ref. 26. For generation of liver-specific Vps15 knockout
mouse line, Vps15 floxed mice were crossed with transgenic mice expressing Cre
recombinase under the control of a Rat albumin promoter30. For the genotyping
genomic DNA isolated from mouse tail snip or tissues was analysed by PCR.
The primer sequences are listed in Supplementary Table S1. The following
combinations of the primers were used: to check presence of distal loxP
sites—LF/LR; to check Cre-mediated excision of the locus—LF/ER. For generation
of liver-specific IR knockout mouse line, mice carrying the LoxP sites flanking the
fourth exon of the IR gene (IRlox/lox stock number: 006955; Jackson laboratory,
USA) were intercrossed with C57BL/6J, which specifically express the Cre
recombinase in the liver under the transthyretin promoter (TTR-CreTam mice; kind
gift of Mireille Vasseur, Institut Cochin, France)67. The resulting IRlox/þ ;TTR-CreTam
mice were interbred with IRlox/lox mice to generate IRlox/lox;TTR-CreTam mice, named
iLIRKO (for inducible liver insulin receptor knockout). To knockout the IR gene,
12-week-old male mice were submitted to an intraperitoneal tamoxifen injection
(1.5mg per mouse) during three consecutive days. The efficient deletion of IR
specifically in hepatocytes was observed 2 weeks postinjection. iLIRKO mice 8 weeks
postinjection with the tamoxifen were used for the in vivo experiments.
Five-week-old male ob/ob and C57Black/6 mice were purchased from Janvier
(France). Mice were acclimatized for 2 weeks in the animal facility before the
initiation of the treatments. Male mice were used for the experimentation. All animal
studies were approved by the Direction De´partementale des Services Ve´te´rinaires,
Pre´fecture de Police, Paris, France (authorization number 75-1313).
Treatments and metabolic studies in vivo. All animals used in the study were fed
ad libitum standard chow diet (Teklad global protein diet; 20% protein, 75%
carbohydrate and 5% fat). Where indicated, mice were fed with HFD (Diet
D12492(I) SNIFF Diet; 20% protein, 20% carbohydrate and 60% fat) for 2 weeks
before manipulations. For 5-bromo-20deoxyuridine (BrdU) incorporation, mice
were treated with BrdU (3mgml 1, Sigma-Aldrich) dissolved in drinking water
for 3 days before killing. Animals were killed between 14:00 and 16:00 unless
indicated. For immunohistochemical analysis liver tissue was fixed overnight in
phosphate-buffered 10% formalin and embedded in paraffin. In all, 6-mm sections
were cut and processed either for staining with eosin/hematoxylin or for
immunohistochemical analyses. Glucose and pyruvate tolerance test were per-
formed in 6-week-old Vps15 LKO mice after an overnight fasting (14 h). Insulin
tolerance test was performed on 6-h starved 6-week-old control and Vps15 LKO
mice. Mice were injected intraperitoneally with glucose (Vps15f/f, Vps15 LKO,
iLIRKO, chow-fed wild-type and HFD-fed wild-type mice—2 g kg 1, ob/ob—
1 g kg 1), Humalog insulin (1m kg 1) or pyruvate (2 g kg 1), and blood was
collected from the tail vein for determination of glucose levels at different time
points using Glucotrend glucometer (Roche Diagnostics). Triglyceride levels in the
acetone extracts of liver tissue were determined using Triglycerides FS Kit (Diasys)
according to the manufacturer’s instructions and as described68.
Cell culture. Mouse hepatoma cell line Hepa1.6 was obtained from American
Type Culture Collection. Immmortalized TSC2 / ;p53 / MEFs and the
littermate-derived pair wild-type control cells were provided by D. J. Kwiatkowski
(Brigham and Women’s Hospital, Boston, MA) and were described previously69.
Cells were maintained in Dulbecco’s modified Eagle’s medium supplemented with
10% foetal bovine serum (FBS), 2mM L-glutamine, 50Uml 1 penicillin and
50 mgml 1 streptomycin. To achieve Vps15 depletion, Hepa1.6 cells and MEFs
were infected with 50 m.o.i. (multiplicity of infection) of Adeno-shRNA Vps15 or
as a control with Adeno shRNA SCR or GFP-expressing vectors. Cells were
collected 48 h later for the analyses. For insulin treatment, 24 h postinfection cells
were starved in Dulbecco’s modified Eagle’s medium without FBS for 24 h and then
were stimulated with insulin (final concentration 1 mM) for indicated times.
Primary hepatocytes from 4–6-week-old mice were isolated by liver perfusion as
described previously68. Hepatocytes were plated at 12 104 cells per cm2 in
Williams medium (Life Technologies) supplemented with 20% FBS, 100 nM
Insulin, 25 nM dexamethasone, penicillin (100Uml 1), streptomycin
(100 mgml 1) and amphotericin B (Fungizone; 250 ngml 1). To achieve Vps15
deletion Vps15f/f hepatocytes 12 h after plating were infected with 10 m.o.i. of
Adeno-CRE or as a control with Adeno-GFP vectors, 2 h after addition of viral
particles the media was changed to Williams medium supplemented with mix of
antibiotics and 25 nM dexamethasone, and when indicated 10% FBS and 100 nM
insulin were added. Cells were collected 72 h later for the analyses. For insulin
treatment, hepatocytes 72 h postinfection were stimulated with 1 mM insulin for
different times.
Glucose production in primary hepatocytes. Primary hepatocytes were plated in
12-well plates. The 12-h post-platting cells were infected with Adeno-shRNA SCR
or Adeno-shRNA Vps15 vectors. The 48-h postinfection cells were washed once
with PBS, and glucose production was determined after 12 h of incubation in Krebs
salts solution supplemented with lactate/pyruvate mix (10:1mM). The amount of
glucose released into the medium was determined by evaluating the production of
NADPH from NADP in the presence of hexokinase and glucose-6-phosphate
dehydrogenase using commercially available kit (Sigma) and normalized to the
total protein content in each well determined by Bradford assay (BioRad).
Subcellular fractionation and endosome preparation. Nuclear extracts
were prepared using NE-PER Kit (Pierce) according to the manufacturer’s
recommendations, from 1 106 cells. Endosomal fraction was purified using
sucrose step gradient as described70. Briefly, cells were washed with PBS and were
pelleted by centrifugation at 200g for 5min. The equal mass of cells was used for
each condition. The pellet was resuspended in homogenization buffer (HB:
250mM sucrose (8.6%), 3mM imidazole (pH 7.4), supplemented with protease
inhibitors (Roche)) and was homogenized by seven passes through a G25 needle.
Post-nuclear supernatant (PNS) was obtained by centrifugation at 2,000g for
10min. Then, sucrose concentration of the PNS was adjusted to 40.6% and PNS
was transferred to SW41 ultracentrifuge tube (Beckman-Coulter). Next, 35%
sucrose in 3mM imidazole buffer (pH 7.4) was layered on PNS up to the top of the
tube. The sample was centrifuged at 210,000g for 3 h at 4 C. Crude endosomes
were collected from the interphase between 35% sucrose and HB buffer.
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Microscopy. For fluorescent microscopy analyses, hepatocytes were grown on
collagen-treated coverslips (Millipore). The 12-h post-plating primary hepatocytes
were transfected with corresponding plasmids using Lipofectamine 2000 reagent as
recommended by the manufacturer (Life Technologies). For the microscopy
analyses 24 h post-transfection cells were fixed with 4% paraformaldehyde in PBS
for 20min and permeabilized with 0.1% saponin in PBS for 10min, followed by
blocking in 3% BSA in PBS. Slides were then treated with primary antibodies for
1 h or directly analysed by fluorescent microscopy. Secondary antibodies used for
these assays were anti-rat IgG Alexa Fluor 635 (Life Technologies) or anti-rabbit
IgG Alexa Fluor 488 or 565 (Life Technologies). Confocal images were acquired
with an optical slice of 0.8 mm using a  40/0.75 oil immersion objective using
LSM 700 confocal microscope (Zeiss) and analysed using ZEN software (Zeiss).
Fluorescence and light microscopy were performed using an inverted microscope
(Eclipse Ti-S; Nikon) and  10/0.30,  20/0.50 or  40/0.785 Plan Fluor
objectives (Nikon). Images were captured using a Super high-definition cooled
colour camera head DS-Ri1 (Nikon) and NIS Elements software (Nikon). All
samples for microscopy were viewed at room temperature.
For spinning disk microscopy, cells plated onto glass-bottom dishes and
transfected with the indicated constructs were imaged for exposure times of 200ms
at 5-s intervals for 240 s using a spinning disk microscope (Andor) based on a
CSU-W1 Yokogawa head mounted on the lateral port of an inverted IX-83
Olympus microscope equipped with a  60 objective lens and a 491 nm 100mW
laser (Andor) used at 40% of maximum power. Images were acquired with a
sCMOS camera (Andor). The system was steered by Metamorph 7 software.
Protein extraction, immunoblotting and immunoprecipitation. To prepare
protein extract for immunoblot analysis, cells were washed twice with cold PBS,
scraped from the dishes in lysis buffer containing 20mM Tris-HCl (pH 8.0), 5%
glycerol, 138mM NaCl, 2.7mM KCl, 1% NP-40, 20mM NaF, 5mM EDTA, 1
protease inhibitors (Roche) and 1 PhosphoStop Inhibitors (Roche). The same
buffer was used to prepare protein extracts from liver tissue. Homogenates were
spun at 12,000g for 10min at 4 C. For immunoprecipitation 1mg of cleared
protein extract was incubated with 1 mg of anti-Flag M2 (Sigma), anti-IRb antibody
(Santa Cruz), anti-UVRAG (MBL) or anti-p85aPI3K antibody (Santa Cruz) for 2 h
at 4 C. Then, immune complexes were pulled down using Protein G Sepharose
beads (GE) during 1 h followed by four washes with extraction buffer. Protein
extracts or immunoprecipitates were resolved by SDS–polyacrylamide gel elec-
trophoresis before transfer onto PVDF membrane followed by incubation with the
primary antibodies and horseradish peroxidase-linked secondary antibodies.
Immobilon Western Chemiluminescent HRP Substrate (Millipore) was used for
the detection.
In vitro Vps34 lipid kinase assay. Cells were lysed in Mild Lysis Buffer (MLB:
10mM Tris, pH7.5, 2mM EDTA, 100mM NaCl, 1% NP-40, 50mM NaF, 1mM
Na3VO4 and protease inhibitor cocktail (Roche)). Total protein extracts were
cleared by 10-min centrifugation at 11,000g. For immunoprecipitation, the
indicated antibody was coupled with protein G Sepharose (GE). The antibody-
conjugated beads were added to the cell lysates and incubated at 4 C for 2 h. Beads
were washed with MLB four times and one time with kinase buffer (KB: 20mM
HEPES (pH 7.4), 1mM EGTA, 0.4mM EDTA and 5mMMgCl2). One-half volume
was then taken for input, the remainder was centrifuged and excess 1 KB was
removed. A volume of 40 ml of 1 kinase assay buffer was added to the beads
supplemented with 0.1mgml 1 phosphatidylinositol, 50 mM cold ATP, 5 mCi
32 P-ATP, 5mM MnCl2 and 50mM dithiothreitol followed by incubation at 37 C
for 30min with vigorous shaking. Reaction was quenched by addition of 10 ml 1M
HCl, followed by lipid extraction with 2 volumes of MeOH:CHCl3 (1:1). Aqueous
phase was discarded and organic phase loaded on a thin layer chromatography
plate (Whatman). Resolution of phospholipid was achieved using a buffer
composition of CHCl:MeOH (99%):NH4OH (30%):Water (129:100:4.29:24).
Resolved plates were analysed by autoradiography.
Real-time quantitative PCR. Total RNA was isolated from tissue by RNAeasy
Lipid Tissue Mini Kit (Qiagen) and RNeasy Mini Kit (Qiagen) from primary
hepatocytes. Single-strand complementary DNA was synthesized from 1 mg of
total RNA using 125 ng of random hexamer primers and SuperScript II (Life
Technologies). Real-time quantitative PCR was performed on MX3005P
instrument (Agilent) using a Brilliant III Ultra-Fast QPCR Master Mix (Agilent).
The relative amounts of the mRNAs studied were determined by means of the
2DDCT method, with pinin or cyclophilin as reference genes and control
treatment or control genotype as the invariant control. The primer sequences
are listed in Supplementary Table S1.
Statistical analysis. A two-tailed Student’s t-test was used for statistical analysis
unless indicated. All data are expressed as means±s.e.m., and significance was
established at the Pr0.05 level.
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